Edition:
United States

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

6.45USD
3:59pm EST
Change (% chg)

$-0.36 (-5.29%)
Prev Close
$6.81
Open
$6.74
Day's High
$6.74
Day's Low
$6.39
Volume
4,285
Avg. Vol
5,571
52-wk High
$10.41
52-wk Low
$4.80

Chart for

About

Arcturus Therapeutics Ltd, formerly Alcobra Ltd, is an Israel-based preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of ribonucleic acid (RNA) medicines using lipid-mediated nanoparticle delivery system (LUNAR) and Unlocked Nucleomonomer Agent (UNA) Oligomer... (more)

Overall

Beta: 1.75
Market Cap(Mil.): $73.54
Shares Outstanding(Mil.): 10.70
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -4.41 -- --
ROI: -60.55 -0.30 13.58
ROE: -69.11 -2.98 15.11

Earnings vs. Estimates